BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6374537)

  • 21. Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study.
    Ausmanas MK; Holinka CF; Ling YS; Christiansen C
    Climacteric; 2007 Aug; 10(4):306-13. PubMed ID: 17653957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
    Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women.
    Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE
    Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the menopause on ischaemic heart disease and its risk factors and on bone mineral content.
    Lindquist O
    Acta Obstet Gynecol Scand Suppl; 1982; 110():1-32. PubMed ID: 6957134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT.
    Rosen HN; Parker RA; Greenspan SL; Iloputaife ID; Bookman L; Chapin D; Perlmutter I; Kessel B; Qvist P; Rosenblatt M
    Calcif Tissue Int; 2004 May; 74(5):415-23. PubMed ID: 14961215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aging skeleton.
    Gordan GS; Genant HK
    Clin Geriatr Med; 1985 Feb; 1(1):95-118. PubMed ID: 3913505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of postmenopausal women for estrogen therapy.
    Christiansen C
    Postgrad Med; 1989 Apr; Spec No():10-2; discussion 33-43. PubMed ID: 2726619
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone loss during oestriol therapy in postmenopausal women.
    Lindsay R; Hart DM; Maclean A; Garwood J; Clark AC; Kraszewski A
    Maturitas; 1979 Jun; 1(4):279-85. PubMed ID: 399316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.
    Lindsay R; Hart DM; Aitken JM; MacDonald EB; Anderson JB; Clarke AC
    Lancet; 1976 May; 1(7968):1038-41. PubMed ID: 57448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of postmenopausal bone loss with estrogens. Which molecule, which scheme, which dose?].
    Jamin C
    Rev Rhum Mal Osteoartic; 1989 May; 56(6):429-32. PubMed ID: 2740806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.
    Ettinger B; Genant HK; Cann CE
    Ann Intern Med; 1987 Jan; 106(1):40-5. PubMed ID: 3789576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term estrogen replacement therapy prevents bone loss and fractures.
    Ettinger B; Genant HK; Cann CE
    Ann Intern Med; 1985 Mar; 102(3):319-24. PubMed ID: 2982302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitonin, estrogens and the bone.
    Gennari C; Agnusdei D
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):451-5. PubMed ID: 2257249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy for osteoporosis with estrogen, fluoride, and calcium.
    Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH
    J Am Geriatr Soc; 1982 Jan; 30(1):13-7. PubMed ID: 7056975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diclofenac sodium inhibits bone resorption in postmenopausal women.
    Bell NH; Hollis BW; Shary JR; Eyre DR; Eastell R; Colwell A; Russell RG
    Am J Med; 1994 Apr; 96(4):349-53. PubMed ID: 8166154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women.
    Recker RR; Saville PD; Heaney RP
    Ann Intern Med; 1977 Dec; 87(6):649-55. PubMed ID: 201203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal bone mineral loss after treatment for malignant gynaecologic tumours.
    Lamke B; Björkholm E
    Acta Radiol Oncol; 1981; 20(2):109-11. PubMed ID: 6270962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of ovariectomy on bone mass. Transverse study using photon densitometry].
    Palummeri E; Gelmini G; Bonati PA; Bergonzani M; Davoli L; Pioli G; Girasole G; Mantovani M; Barbagallo M; Pedrazzoni M
    Minerva Ginecol; 1987 Sep; 39(9):607-13. PubMed ID: 3683966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.